Main Article Content
Aim: This study was aimed at assessing some haemostatic parameters of women with spontaneous abortion attending antenatal clinics in Yenagoa, Bayelsa State.
Study design: This study is a crossectional study.
Place and Duration of Study: This study was carried out in Federal Medical Centre (FMC) and Diete Koki Hospital, all in Yenagoa, Bayelsa State, Nigeria, between October 2018 and July 2019.
Methodology: A total of eighty-eight (88) subjects (48 women with spontaneous abortion and 40 women with normal pregnancy) were enrolled in this study. Ten (10) mls of blood sample was obtained from each participant. Platelet count and mean platelet volume were determined using the Mindray BC-5300 (Shenzhen Mindray Bio-Medical Electronics Co. Ltd China) Auto haematology analyzer. Prothrombin time was determined using Erba Actime invitro diagnostic reagent kits, activated partial thromboplastin time was determined using Erba Protime and Erba Calcium invitro diagnostic reagent kits, Fibrinogen was determined using Erba invitro reagents. Thrombin and antithrombin were determined using Erba Chrom kits while tissue plasminogen activator and tissue Plasminogen were determined using ELISA assay kits (Elabscience Biotech. Co. Ltd China). Data analysis was done using GraphPad Prism version 5.1 and p-values < 0.05 were considered statistically significant.
Results: Results showed a statistically significant decrease in aPTT (27.42 ± 7.827s versus 22. 60 ± 7.038s) (P=.003) among test and control groups irrespective of trimester, mean platelet volume (MPV) (10.76fl ± 1.89 versus 8.89 ± 1.00fl) (P =.004) among test and control groups in the first trimester. A significant decrease in activated partial thromboplastin time (28.44 ± 8.64s versus 21.82 ± 6.87s) (P=.0019) and antithrombin (32.57 ± 10.83% versus 16.34 ± 6.20%) (P =.001) among test and controls in the second trimester were observed. Also, a statistical decrease were observed in aPTT (32.00 ± 6.12s versus 20.36 ± 5.853s) (P= .0027) and (31.14 ± 9.083s versus 21.57 ± 9.343s) (P =.036) in the second trimester within the age ranges 18-23years and 31-36years. A significant negative correlations were observed in the test subjects for the first trimester between tissue in plasminogen and age mean platelet volume and platelet count and mean platelet volume and tissue plasminogen activator; second trimester test subjects between Platelet and age), antithrombin and platelet.
Conclusion: In conclusion, the findings suggest that the haemostatic parameters may contribute to complications in pregnancy.
World Health Organization (WHO). .Definition of spontaneous abortion: Miscarriage/Ovulation Guide; 2014.
Antonette T, Dulay MD. Spontaneous Abortion (Miscarriage). Obstetric Gynaecology. 2018; 144(4):1254-59.
Adeniran AS, Fawole AA, Abdul IF, Adesina KT. Spontaneous abortions (miscarriages): Analysis of cases at a tertiary center in North Central Nigeria. Journal of Medical Tropics. 2015; 17:22-6.
Akinrinola B, Isaac F, Adewole RH, Olutosin A, Susheela S, Joshua OA. The Incidence of Abortion in Nigeria. International Perspective Sex Reproduction Health. 2015;41(4):170-81.
Abiodun SA, Adegboyega AF, Ishaq FA, Kikelomo TA. Spontaneous abortions (miscarriages): Analysis of cases at a tertiary center in North Central Nigeria. Obstetrics and Gynaecology. 2015;23:123-33.
Ammon AL, Galindo C, Li DK. A systematic review to calculate background miscarriage rates using life table analysis. Birth defects research. Part a Clinical and Molecular Teratology. 2012; 94 (6):417–23.
Erhabor O, Isaac Z, Yakubu A, Adias TC. Ectopic pregnancy and miscarriages in Sub Sahara Africa: Challenges of Rhesus Isoimmunisation in Rhesus negative women. Journal of Obstetrics and Gynaecology. 2013;3:15-26.
Bocciolone L, Parazzini F, Fedele L, Acaia B, Candiani GB. Epidemiology of spontaneous abortion: A review of the literature. Annali di Ostetricia Ginecologia Medicinia Perinatale. 1998; 110(6):323-34.
Everett C. Incidence and outcome of bleeding before the 20th week of pregnancy: Prospective study from general practice. British Medical Journal. 2017;315(7099):32–34.
Akinyele TR. Isaac Adaka Boro: Patriach of Minority activism in the Niger Delta, University of Lagos, Faculty of Arts; 2006.
Iyarokpo J. Impact of rapid urbanization on environmental quality in Yenagoa metropolis, Bayelsa state – Nigeria. European Scientific Journal. 2015;11(23):255–68.
Abbassi-Ghanavati M, Greer LG, Cumungham FG. Pregnancy and laboratory studies. A reference table for clinician. Obstetrics and Gynaecology. 2009;114(6):1326-27.
Ogasawara M, Aoki K, Katano K, Aoyama T, Ozaki Y, Sizemore K. Activated partial thromboplastin time is a predictive parameter for further miscarriages in cases of recurrent fetal loss. Fertility Sterility. 1999;70(6):1081-84.
Ibeh N, Okocha CE, Aneke CJ, Onah CE, Nwosu AO, Nkwazema KA. Normal pregnancy and coagulation profile: From the first through the third trimester. Nigerian Journal Medicine. 2015; 24(1):54-7.
Piazze J, Gioia S, Spagnuolo A, Cerekja A. Platelets in pregnancy. Journal Prenatal Medicine. 2011;5(4):0–2.
Mustafa K, Tuncay Y, Mehmet B. Decreased mean platelet volume is associated with the developing stage of fetoplacental unit in spontaneous abortion. International Journal of Clinical and Experimental Medicine. 2005;8(7):11301-06.
Bick RL. Recurrent miscarriage syndrome due to blood coagulation protein/platelet defects: Prevalence, treatment and outcome results. Metroplex Recurrent Miscarriage Syndrome Cooperative Group. Clinical and Applied Thrombosis Hemostasis. 2005;6(3):115-25.
Hara T, Naito K. Inherited antithrombin deficiency and end stage renal disease. Medical Science Monitor. 2005;11(11):346-54.
Milton BA. Antithrombin Deficiency. Medscape.
Availble: http://emedicine.medscape.com/ article/198573-overview Updated. 2015;21.
Accessed January 25, 2018.
Ymer M, Shefqet L, Fetie D, Naser R, Ermira M, Hakif H, et al. Prevalence and role of antithrombin III, protein C and protein S deficiencies and activated protein C resistance in Kosovo women with recurrent pregnancy loss during the first trimester of pregnancy. Journal Human Reproductive Science. 2015;8(4):224–9.
Von Wersch JW, Ubachs JM. Blood Coagulation and Fibrinolysis during Normal Pregnancy. European Journal of Clinical Chemistry. 1991;99:45-50.
Magdy HS, Carlos AM. The Use of Tissue Plasminogen-activator in Pregnancy. Stroke. 2013; 44:868-9
Vagdatli E, Gounari E, Lazaridou E, Katsibourlia E, Tsikopoulou F, Labrianou I. Platelet distribution width: A simple, practical and specific marker of activation of coagulation Hippokratia. 2010;14(1):28–32.
Piazze J, Gioia S, Spagnuolo A, Cerekja A. Platelets in pregnancy. Journal Prenatal Medicine, 2011;5(4):90–2.
Carlo LB, Patrizia N. Platelet count and age. Haematologica. 2014;99(6):953-55.
Imoru M, Buseri FI Fiekumo IB. Altered haemostatic values during pregnancy in North West Nigeria. Do maternal Age and parity play any role. Haematology and thromboembolic disease. 2015;3:180-8.
Valera MC, Parant O, Vayssiere C, Arnal JF, Payrastre B. Physiologic and pathologic changes of platelets in pregnancy. Platelets. 2010;21:587–95.
Robert L, Uwe K. Volker S, Volker T, Rüdiger ES, Aleksandar V. Antithrombin significantly influences platelet adhesion onto immobilized fibrinogen in an in-vitro system simulating low flow. Thrombosis. 2006;(19):457-68.